Azerbaijan vs Gambia: Share of children with symptoms of a respiratory infection who received antibiotics
Azerbaijan
47.5%
in 2018
Gambia
48.1%
in 2018
Azerbaijan rank
85th
Gambia rank
83rd
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Azerbaijan
- Gambia
How they compare
Gambia currently reports 48.1% against 47.5% in Azerbaijan, a difference of 0.6%.
The two have swapped places 3 times across 19 shared years of data; in 2000 it was Azerbaijan ahead.
Azerbaijan ranks 85th and Gambia ranks 83rd of 132 countries.
Across the 2 decades both report, Azerbaijan averaged higher in 1 and Gambia in 1.
Head to head by decade
| Decade | Azerbaijan | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.8% | 60.8% | 2.0% | Azerbaijan |
| 2010s | 54.1% | 61.9% | 7.9% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Azerbaijan or Gambia?
- Gambia, at 48.1% against 47.5% in Azerbaijan as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Azerbaijan and Gambia?
- 0.6%, with Gambia ahead.
- How many years of comparable data are there for Azerbaijan and Gambia?
- 19 years are reported by both, from 2000 to 2018.
- How do Azerbaijan and Gambia rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Azerbaijan ranks 85th and Gambia ranks 83rd of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.